DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
von Minckwitz G, Graf E, Geberth M. et al.
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).
Eur J Cancer 2006;
42: 1780-1788
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.